【摘要】：降鈣素是一類對(duì)生物機(jī)體有重要作用的肽類激素,可以作為許多疾病如高血鈣癥、骨質(zhì)疏松癥、Paget病等的治療藥物。由于實(shí)驗(yàn)上發(fā)現(xiàn)它能夠自組裝成納米粒子,而納米粒子在藥物緩釋載體方面有重要的應(yīng)用,而且由于降鈣素本身是多肽,生物相容性好;并且降鈣素本身也可以作為藥物�；谝陨系睦碛�,我們有必要對(duì)它的自組裝過(guò)程的機(jī)制進(jìn)行深入的研究。實(shí)驗(yàn)上的發(fā)現(xiàn)還包括二肽和降鈣素能一起自組裝成納米粒子,并且能改變納米粒子的外部形態(tài);在只含降鈣素的體系中納米粒子呈現(xiàn)成桿狀,而和二肽一起自組裝時(shí)納米粒子為粒子狀。本文采用動(dòng)力學(xué)模擬、分子對(duì)接等手段來(lái)研究它們的機(jī)制,以期對(duì)以后合成藥物載體提供指導(dǎo)和建議。本文采用循序漸進(jìn)的方法來(lái)研究它們的機(jī)制;先利用分子對(duì)接、動(dòng)力學(xué)模擬以及能量計(jì)算等手段來(lái)研究單個(gè)降鈣素和單個(gè)降鈣素之間以及單個(gè)降鈣素和單個(gè)二肽之間的結(jié)合機(jī)制。我們通過(guò)對(duì)能量的分析發(fā)現(xiàn),降鈣素之間主要是通過(guò)范德華作用力來(lái)結(jié)合的初步結(jié)論。而通過(guò)對(duì)不同種類的降鈣素二肽體系結(jié)果進(jìn)行比較可以發(fā)現(xiàn),二降鈣素和二肽分子的結(jié)合過(guò)程中,靜電作用起到了關(guān)鍵性的作用。之后我們通過(guò)構(gòu)建相對(duì)較小的降鈣素和二肽DF體系來(lái)進(jìn)行全原子的動(dòng)力學(xué)模擬,以期得到降鈣素二肽DF一起組裝時(shí)的機(jī)制。我們通對(duì)降鈣素的二級(jí)結(jié)構(gòu)的統(tǒng)計(jì),降鈣素表面靜電勢(shì)的計(jì)算,以及結(jié)合到降鈣素上的二肽的數(shù)目的統(tǒng)計(jì)來(lái)對(duì)自組裝過(guò)程機(jī)制進(jìn)行描述和推斷。并對(duì)降鈣素納米粒子的形態(tài)轉(zhuǎn)變進(jìn)行了理論上的解釋。結(jié)論是:自組裝過(guò)程以降鈣素為主導(dǎo),二肽則在不斷地尋找合適的位置結(jié)合到降鈣素上去,對(duì)于二肽DF,它主要是以靜電作用結(jié)合到降鈣素上去的。最后我們利用粗粒度模型來(lái)對(duì)自組裝全過(guò)程進(jìn)行模擬,設(shè)計(jì)了幾種不同性質(zhì)的二肽來(lái)和降鈣素一起進(jìn)行自組裝。通過(guò)對(duì)軌跡的對(duì)比我們發(fā)現(xiàn)具有強(qiáng)疏水作用性質(zhì)的殘基能很好地和降鈣素一起進(jìn)行自組裝。這說(shuō)明強(qiáng)的疏水作用在自組裝過(guò)程中也起到了關(guān)鍵性的作用。
[Abstract]:Calcitonin is a kind of peptide hormone which plays an important role in organism. It can be used as a treatment for many diseases such as hypercalcemia, osteoporosis, Paget's disease and so on. It is found that it can self-assemble into nanoparticles, and nanoparticles have important applications in drug delivery support, and because calcitonin itself is a polypeptide, it has good biocompatibility, and calcitonin itself can also be used as a drug. For these reasons, it is necessary to study the mechanism of self-assembly. The experimental findings include that dipeptides and calcitonin can self-assemble into nanoparticles together, and can change the external morphology of nanoparticles; In the system containing calcitonin only, the nanocrystalline particles take on the shape of rods, while the nanoparticles are particles when self-assembled with dipeptide. In this paper, kinetic simulation and molecular docking were used to study their mechanism in order to provide guidance and advice for the synthesis of drug carriers in the future. In this paper, a step-by-step approach is adopted to study their mechanisms. The binding mechanism between single calcitonin and single dipeptide was studied by molecular docking kinetic simulation and energy calculation. Our energy analysis shows that calcitonin is mainly bound by van der Waals force. By comparing the results of different calcitonin dipeptide systems, it is found that electrostatic action plays a key role in the binding process of dicalcitonin and dipeptide molecules. Then we construct a relatively small calcitonin and dipeptide DF system to simulate the kinetics of the whole atom in order to obtain the mechanism of calcitonin dipeptide DF assembled together. The secondary structure of calcitonin, the calculation of the surface electrostatic potential of calcitonin and the statistics of the number of dipeptides combined with calcitonin are used to describe and infer the mechanism of the self-assembly process. The morphological transition of calcitonin nanoparticles was explained theoretically. The conclusion is that calcitonin is dominant in the self-assembly process and the dipeptide is constantly searching for a suitable position to bind to the calcitonin. For the dipeptide DF, it is mainly bound to calcitonin by electrostatic action. Finally, we simulate the whole process of self-assembly by coarse-grained model, and design several dipeptides with different properties to self-assemble with calcitonin. By contrasting the trajectories, we find that the residues with strong hydrophobicity can self-assemble well with calcitonin. This indicates that strong hydrophobic action also plays a key role in self-assembly process.
【學(xué)位授予單位】：電子科技大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R3411

【參考文獻(xiàn)】

相關(guān)期刊論文 前1條

1 張玉彬,吳梧桐,吳文俊;降鈣素的研究進(jìn)展[J];中國(guó)藥學(xué)雜志;1996年08期

相關(guān)博士學(xué)位論文 前1條

1 扈國(guó)棟;幾個(gè)生物體系的分子動(dòng)力學(xué)模擬和自由能計(jì)算研究[D];山東師范大學(xué);2011年

相關(guān)碩士學(xué)位論文 前2條

1 劉英華;兩親性納米載藥系統(tǒng)的制備與性能研究[D];中國(guó)海洋大學(xué);2014年

2 熊玉翠;聚羥基脂肪酸酯納米顆粒作為藥物緩釋載體的應(yīng)用[D];汕頭大學(xué);2010年

，

本文編號(hào)：2310553